Compare DIOD & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DIOD | BLLN |
|---|---|---|
| Founded | 1959 | 2016 |
| Country | United States | United States |
| Employees | N/A | 713 |
| Industry | Semiconductors | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.9B |
| IPO Year | 1995 | N/A |
| Metric | DIOD | BLLN |
|---|---|---|
| Price | $99.40 | $86.22 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 7 |
| Target Price | $92.67 | ★ $126.71 |
| AVG Volume (30 Days) | ★ 655.9K | 620.6K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.53 | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $18.08 | $46.29 |
| Revenue Next Year | $14.46 | $30.14 |
| P/E Ratio | $300.11 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $42.28 | $61.96 |
| 52 Week High | $117.80 | $138.70 |
| Indicator | DIOD | BLLN |
|---|---|---|
| Relative Strength Index (RSI) | 51.66 | 51.80 |
| Support Level | $95.08 | $81.06 |
| Resistance Level | $117.80 | $97.36 |
| Average True Range (ATR) | 5.45 | 8.62 |
| MACD | -2.35 | -0.51 |
| Stochastic Oscillator | 31.46 | 41.41 |
Diodes Inc is a manufacturer and supplier of high-quality application-specific products within the broad discrete, logic, analog, and mixed-signal semiconductor markets. It serves the customer electronics, computing, communications, industrial, and automotive markets. The Company's products include diodes; rectifiers; transistors; MOSFETs; GPP bridges; GPP rectifiers; protection devices; function-specific arrays; single gate logic; amplifiers and comparators; Hall-effect and temperature sensors; and power management devices, including LED drivers, AC-DC converters and controllers, DC-DC switching and linear voltage regulators, voltage references along with special-function devices, such as USB power switches, load switches, voltage supervisors, and motor controllers.
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.